Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Cathie Wood's ARK ETF bolsters biotech, cuts sports data stock

Published 27/08/2024, 10:06 am
MTEM
-
GNE
-
ARCT
-
SHOP
-
ARKG
-
ARKK
-
ARKW
-
DKNG
-

Cathie Wood's ARK ETFs conducted a series of trades on Monday, August 26, 2024, with a notable emphasis on biotech acquisitions and a significant divestment in sports data. The day's largest transaction involved the sale of shares in GENIUS SPORTS LTD (NYSE:GENI) from the ARKW ETF, with a total dollar value of $3,625,498. This move comes as the most substantial sale for the day, overshadowing the buying activity in the biotech sector.

On the purchasing front, ARK's ARKG and ARKK funds continued their focus on biotech and technology firms. TEMPUS AI INC (NASDAQ:TEM) saw the largest influx of capital, with ARK buying 59,585 shares across the ARKK and ARKG ETFs, totaling $3,870,045. This investment underscores ARK's growing confidence in the health technology sector and marks the highest dollar-value trade in terms of buying.

Not far behind was DRAFTKINGS INC (NASDAQ:DKNG), with the ARKW ETF acquiring 51,314 shares for a total of $1,866,290. The consistent interest in DraftKings (NASDAQ:DKNG) suggests a bullish stance on the online sports betting company, despite the significant sale in GENIUS SPORTS LTD.

Another significant buy was SHOPIFY INC (NYSE:SHOP), with the ARKW ETF purchasing 25,265 shares, amounting to $1,923,677. This move aligns with ARK's ongoing investment strategy in e-commerce platforms, which have shown resilience and growth potential in the digital economy.

The ARKG ETF also increased its holdings in ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ:ARCT) by buying 44,875 shares, valued at $986,801. This follows a trend observed since last week, with ARK consistently boosting its position in ARCTURUS, suggesting a strategic bet on the company's long-term prospects in the biotech industry.

Other notable buys include GUARDANT HEALTH INC (NASDAQ:GH) with 29,147 shares acquired for $845,845, and ROBLOX CORP (NYSE:RBLX) with 13,432 shares bought at a value of $593,157. These trades reflect ARK's diversified approach, balancing investments across different sectors with a keen eye on innovative companies.

On the selling side, ARK reduced its exposure to VERVE THERAPEUTICS INC (NASDAQ:VERV) by offloading 285,575 shares for $1,410,740, and MATERIALISE NV (NASDAQ:MTLS) with 55,728 shares sold totaling $306,504. Smaller sales were also executed in 908 DEVICES INC. (NASDAQ:MASS) and VUZIX CORP (NASDAQ:VUZI), totaling $36,418 and $2,863, respectively.

The daily trade report from Cathie Wood's ARK ETFs offers investors a glimpse into the fund's latest strategic moves, highlighting a continued appetite for innovative companies, particularly in the biotech and technology sectors, while adjusting holdings in response to market dynamics and portfolio strategy.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.